Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy

Background Data to guide dialysis decision-making for transplant-ineligible patients with cirrhosis are lacking. Aims We aimed to describe the processes, predictors, and outcomes of renal replacement therapy (RRT) initiation for transplant-ineligible patients with cirrhosis at a single liver transpl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2024-10, Vol.69 (10), p.3710-3720
Hauptverfasser: Diaz, Paige McLean, Saly, Danielle L., Horick, Nora, Petrosyan, Romela, Gitto, Zachary, Indriolo, Teresa, Li, Lucinda, Kahn-Boesel, Olivia, Donlan, John, Robinson, Blair, Dow, Lindsay, Liu, Annie, El-Jawahri, Areej, Parada, Xavier Vela, Combs, Sara, Teixeira, Joao, Chung, Raymond, Allegretti, Andrew S., Ufere, Nneka N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Data to guide dialysis decision-making for transplant-ineligible patients with cirrhosis are lacking. Aims We aimed to describe the processes, predictors, and outcomes of renal replacement therapy (RRT) initiation for transplant-ineligible patients with cirrhosis at a single liver transplantation center. Methods We conducted a mixed-methods study of a retrospective cohort of 372 transplant-ineligible inpatients with cirrhosis with acute kidney injury (AKI) due to hepatorenal syndrome (HRS-AKI) or acute tubular necrosis (ATN) between 2008 and 2015. We performed survival analyses to evaluate 6-month survival and renal recovery and examined end-of-life care outcomes. We used a consensus-driven medical record review to characterize processes leading to RRT initiation. Results We identified 266 (71.5%) patients who received RRT and 106 (28.5%) who did not receive RRT (non-RRT). Median survival was 12.5 days (RRT) vs. 2.0 days (non-RRT) (HR 0.36, 95%CI 0.28–0.46); 6-month survival was 15% (RRT) vs. 0% (non-RRT). RRT patients were more likely to die in the intensive care unit (88% vs. 32%, p  
ISSN:0163-2116
1573-2568
1573-2568
DOI:10.1007/s10620-024-08623-2